Telephone & Addresses
Yutaka Natsumeda, 49, Blue Bell, US, Sentry Pkwy
View Yutaka's social profiles and photos on Facebook, MySpace, and +40 Networks.
Yutaka Natsumeda, 49, Kenilworth, US, Galloping Hill Rd
View Yutaka's social profiles and photos on Facebook, MySpace, and +40 Networks.
Network Profiles
LinkedIn: Yutaka Natsumeda - 동명이인 보기 - LinkedIn
Yutaka Natsumeda 님의 LinkedIn 프로필 보기 LinkedIn은 Yutaka Natsumeda 님과 같은 인재들이 다른 인재, 분야 전문가, 비즈니스 파트너 등과 인맥을 맺도록 ...
Interests
New mutation identified, associated with better survival in lung...
www.sciencedaily.com
Researchers have identified a mutation associated with a higher incidence of lung cancer in Japanese women who do not smoke, but who appear to have a better...
Education
View Printer-Friendly Document
webapp1.dlib.indiana.edu
C.(50) For Yutaka Natsumeda, reappointment as Visiting Assistant Professor of Experimental Oncology, School of Medicine, for the period July 1, to March 31, C.(51) For William R. Nunery, a change in title from Assistant Professor, part-time, to Assistant Professor of Ophthalmology, School of ...
Books & Literature
Yutaka Natsumeda | XanEdu Customization Platform
www.academicpub.com
Author: Yutaka Natsumeda. Results. Phase I and pharmacokinetic study of edotecarin, a novel topoisomerase I inhibitor, administered once every 3 weeks in ...
DSpace
dea.lib.unideb.hu
Prajda Noémi; Yutaka Natsumeda; Tadashi Ikegami; Melissa.A.Reardon; Szondy Zsuzsa; Yasuko Yashimoto; Jahangir Emrani; Szondy Zsuzsa (1959-) ...
SNP (–617C>A) in ARE-Like Loci of the NRF2 Gene: A New Biomarker for...
journals.plos.org
Affiliations Omics Science Center, RIKEN Yokohama Institute, Yokohama, Japan, Respiratory Disease Center, Yokohama City University Medical Center, Yokohama, Japan. Yutaka Natsumeda. Affiliation Department of Clinical Research, Yokohama City University Graduate School of Medicine, Yokohama, ...
Purine and Pyrimidine Metabolism in Man V: Part B: Basic Science...
books.google.de
PURINE SYNTHETIC CAPACITIES OF DE NOWO AND SALWAGE PATHWAYS IN RAT HEPATOMA A CELLS Yutaka Natsumeda, Tadashi Ikegami and George Weber Indiana University School of Medicine, Laboratory for Experimental Oncology, Indianapolis, IN, U.S.A. INTRODUCTION The relative contribution of de ...
Related Documents
OpenClinica Enterprise for Clinical Trial in Japan - Community
community.openclinica.com
Virtual Patient Population Convergence: A New Framework for Translational Biomedical Informatics. 8. Hiroshi Tanaka. Structure of protein interaction network and their implication on drug design Yutaka Natsumeda. Status of translational and clinical research in Japan and YCU's vision. 10.
SNP (–617C>A) in ARE-Like Loci of the NRF2 Gene: A New Biomarker for...
www.deepdyve.com
Yutaka Natsumeda. 9. , Tomoyuki Yokose , Haruhiko Nakayama , Yohei Miyagi ,. Toshihisa Ishikawa. 1. *. 1 Omics Science Center ...
Phase I and pharmacokinetic study of edotecarin, a novel...
www.deepdyve.com
J. Patrick McGovren Æ Yutaka Natsumeda. Phase I and pharmacokinetic study of edotecarin, a novel topoisomerase I. inhibitor, administered once every
Scientific Publications
Salvage pathways as targets of chemotherapy - ScienceDirect
www.sciencedirect.com
PILLWEIN, YUTAKA NATSUMEDA, MELISSA A. REARDON and. YONG-SU ZHEN. Laboratory for Experimental Oneology, Indiana University School of Medicine,. Indianapolis, IN INTRODUCTION. This presentation discusses the significance of the activities of purine and pyrimidine salvage pathways in cancer cells ...
Publications
Phase I and pharmacokinetic study of edotecarin, a novel...
link.springer.com
... McGovren (4); Yutaka Natsumeda (5). Author Affiliations. 1. Department of Medical Oncology, National Cancer Center Hospital, Tsukiji, ...
Purine Synthetic Capacities of De Novo and Salvage Pathways in Rat...
link.springer.com
The relative contribution of de
novo and salvage pathways for nucleotide synthesis in neoplastic tissues is one of the important factors in cancer...
A phase I study of the safety and pharmacokinetics of edotecarin...
link.springer.com
Samit Hirawat · William P. Petros · Yutaka Natsumeda ·. Tomoko Yoshinari. Received: 16 June Accepted: 9 May Published online: 4 July
Oalib search
www.oalib.com
Abstract: Purpose The transcription factor NRF2 plays a pivotal role in protecting normal cells from external toxic challenges and oxidative ...
Personal - Miscellaneous
1212 Parkinson, Palo Alto CA | MyRelatives
www.myrelatives.com
View Full Profile. Makiko Natsumeda. Age: 49. Previous Addresses: 10 Sentry Pkwy Blue Bell Pa Edgewood Dr Palo Alto Ca Galloping Hill Rd Kenilworth Nj 1 more Possible Addresses. Possible Relatives Relatives: Yutaka Natsumeda. Date of Residency Date of Residency: Phone. Email. View Full Profile.
Miscellaneous
Yutaka Natsumeda | LinkedIn
www.linkedin.com
View Yutaka Natsumeda's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Yutaka Natsumeda ...
Yutaka Natsumeda | LinkedIn
www.linkedin.com
Yutaka Natsumedas berufliches Profil anzeigen LinkedIn ist das weltweit größte berufliche Netzwerk, das Fach- und Führungskräften wie Yutaka Natsumeda ...
A phase I study of the safety and pharmacokinetics of edotecarin...
www.infona.pl
... with advanced solid tumors. Herbert I. Hurwitz, Roger B. Cohen, J. Patrick McGovren, Samit Hirawat, William P. Petros, Yutaka Natsumeda, Tomoko Yoshinari.
HUM-MOLGEN events: Partnerships in Clinical Trials Asia
hum-molgen.org
central resource for events in human genetics and molecular biology
IEICE Technical Report, vol 115, no 438, 2016
ken.ieice.org
MICT [Invited Talk] The key supports for developing new drugs and medical devices in Japan Yutaka Natsumeda (KSLION) pp MICT
Masahiko Inamori - Publications List
publicationslist.org
... Kenichi Kawana, Yutaka Natsumeda, Hajime Nagase, Atsushi Nakajima (2011) Capsule-endoscopic findings of ulcerative colitis patients. Digestion 84: 4.
PLOS ONE: SNP (–617C>A) in ARE-Like Loci of the NRF2 Gene: A New...
journals.plos.org
PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all...
Phase I and pharmacokinetic study of edotecarin, a novel...
keio.pure.elsevier.com
... Yutaka Ueda ; Haruyasu Murakami ; Hitoshi Kusaba ; Yoshikazu Kamiya ; Hideo Saka ; Yusuke Tanigawara ; J. Patrick McGovren ; Yutaka Natsumeda.
OC13 - Breakout 3 Sessions - OpenClinica
community.openclinica.com
Yutaka Natsumeda, MD., PhD. Chairman at KSLION (Key Support for Life Innovation ). Summary: Japan is competitive in basic research and has made many ...
研究会 - 日本の医薬品・医療機器開発の現状と開発支援の鍵
ken.ieice.org
キーワード(7)（和/英）, パートナリング / Partnering. キーワード(8)（和/英）, /. 第1著者 氏名（和/英/ヨミ）, 棗田 豊 / Yutaka Natsumeda / ナツメダ ユタカ. 第1著者 所属（和/英）, ライフイノベーション総合支援機構 (略称： KSLION) Key Support for Life Innovation (略称： KSLION). 第2著者 氏名（和/英/ヨミ）, 第2著者 所属（和/英） ...
SNP (–617C>A) in ARE-Like Loci of the NRF2 Gene: A New Biomarker for...
figshare.com
... Taguri Yasushi Ichikawa Takeshi Kaneko Yutaka Natsumeda Tomoyuki Yokose Haruhiko Nakayama Yohei Miyagi Toshihisa Ishikawa.
Yutaka Natsumeda | LinkedIn
www.linkedin.com
Yutaka Natsumeda. Experience: Executive Director, Merck; Senior Staff Scientst, Syntex Corp.; Associate Professor, Indiana University School of Medicine. I joined
InCoB Tokyo Committees
incob.apbionet.org
Yutaka Natsumeda (CBI Workshop), Yokohama City University, Japan; Yasushi Okazaki, Saitama Medical University, Japan; Akinori Sarai, Kyushu Institute of Technology, Japan
Related search requests for Yutaka Natsumeda
| Takeshi Kaneko Haruhiko Nakayama George Weber |
People Forename "Yutaka" (985) Name "Natsumeda" (2) |
sorted by relevance / date